3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Carcinoma
2
Prostatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Vincristine
3
Temozolomide
3
Specimen Handling
3
Irinotecan
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Radiotherapy
2
temsirolimus
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
erdafitinib
1
cabozantinib
1
atezolizumab
1
Vinorelbine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
ALT-803
×
30 days
×
Clear all
No trials found.